Alexander A Vinks

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Venues

Clinical pharmacology and therapeutics

Drug metabolism and disposition: the biological fate of chemicals

British journal of clinical pharmacology

Journal of clinical pharmacology

Cincinnati Children's Hospital Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cincinnati Children's Hospital Medical Center Aug 01 2000

United States

Cincinnati Children’s Research Foundation Endowed Chair :: Division of Clinical Pharmacology

Publications

Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and verification of a full physiologically-based pharmacokinetic model for sublingual buprenorphine in healthy adult volunteers that accounts for nonlinear bioavailability. Drug metabolism and disposition: the biological fate of chemicals (2024)
Nicole K Wilson, Simon Tremblay, Adele Rike Shields, Ervin Steve Woodle, Raymond T Chung, Alexander A Vinks, Bradley Miyagawa, Tomoyuki Mizuno
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations. Transplantation direct 10 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Nicole K Wilson, Simon Tremblay, Adele Rike Shields, Ervin Steve Woodle, Raymond T Chung, Alexander A Vinks, Bradley Miyagawa, Tomoyuki Mizuno
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations. Transplantation direct 10 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Kana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, Min Dong, Peter C Adamson, Jeffery L Blumer, Avital Cnaan, Peggy O Clark, Michael D Reed, Shlomo Shinnar, Alexander A Vinks, Tracy A Glauser, null null
Model-informed Precision Dosing Guidance of Ethosuximide Developed From a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy. Clinical pharmacology and therapeutics (2023)
Sonata Jodele, Kana Mizuno, Anthony Sabulski, Alexander A Vinks
Adopting Model-Informed Precision-Dosing for Eculizumab in Transplant Associated-Thrombotic Microangiopathy to Gene Therapies. Clinical pharmacology and therapeutics (2023)
Alexandra Power-Hays, Min Dong, Nieko C Punt, Tomoyuki Mizuno, Luke R Smart, Alexander A Vinks, Russell E Ware
Rationale, development, and validation of HdxSim, a clinical decision support tool for model-informed precision dosing (MIPD) of hydroxyurea for children with sickle cell anemia. Clinical pharmacology and therapeutics (2023)
Yewon Choi, Alexander A Vinks, Piet H van der Graaf
Novel Therapeutic Modalities: The Future is Now. Clinical pharmacology and therapeutics 114 (3) (2023)
Ruben J Colman, Tomoyuki Mizuno, Keizo Fukushima, David B Haslam, Jeffrey S Hyams, Brendan Boyle, Joshua D Noe, Geert R A M D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Lee A Denson, Nicholas J Ollberding, Alexander A Vinks, Phillip Paul Minar
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary pharmacology & therapeutics (2022)
Jeffrey S Barret, Ryan F Barrett, Alexander A Vinks
Status Toward the Implementation of Precision Dosing in Children. Journal of clinical pharmacology (2022)
Alexander A Vinks, Jeffrey S Barret
Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children. Journal of clinical pharmacology (2022)
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Jaishri O Blakely, Jeffrey C Allen, Elizabeth K Schorry, Bruce R Korf, Nathan J Robison, Stewart Goldman, Alexander A Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta T Robinson, Gary R Cutter, Lloyd J Edwards, Eva Dombi, Nancy Ratner, Roger Packer, Michael J Fisher
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Sharat Chandra, Kana Mizuno, Junfang Zhao, Stella M Davies, Rebecca A Marsh, Tsuyoshi Fukuda, Kenneth D R Setchell, Alexander A Vinks, Parinda A Mehta
Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. British journal of clinical pharmacology (2021)
Matthijs W van Hoogdalem, Trevor N Johnson, Brooks T McPhail, Suyog Kamatkar, Scott L Wexelblatt, Laura P Ward, Uwe Christians, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome. Clinical pharmacology and therapeutics (2021)
Ruben J Colman, Ye Xiong, Tomoyuki Mizuno, Jeffrey S Hyams, Joshua D Noe, Brendan Boyle, Geert R D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Michael J Rosen, Lee A Denson, Alexander A Vinks, Phillip Paul Minar
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary pharmacology & therapeutics 55 (5) (2021)
Min Dong, Chie Emoto, Tsuyoshi Fukuda, Danielle E Arnold, Parinda A Mehta, Rebecca A Marsh, Alexander A Vinks
Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation. British journal of clinical pharmacology (2021)
Tomoyuki Mizuno, Min Dong, Zachary L Taylor, Laura B Ramsey, Alexander A Vinks
Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care. British journal of clinical pharmacology (2020)
Matthijs W van Hoogdalem, Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, Parinda A Mehta, Alexander A Vinks
Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients. British journal of clinical pharmacology 86 (5) (2020)
Zachary L Taylor, Tomoyuki Mizuno, Nieko C Punt, Balaji Baskaran, Adriana Navarro Sainz, William Shuman, Nicholas Felicelli, Alexander A Vinks, Jesper Heldrup, Laura B Ramsey
MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase. Clinical pharmacology and therapeutics 108 (3) (2020)
Alexander A Boucher, Min Dong, Alexander A Vinks, Anu Marahatta, Thad A Howard, Russell E Ware, Jaimie D Nathan, Maisam Abu-El-Haija, Lori Luchtman-Jones
Hydroxyurea Pharmacokinetics in Pediatric Patients After Total Pancreatectomy With Islet Autotransplantation. Journal of clinical pharmacology 61 (4) (2020)
Matthijs W van Hoogdalem, Brooks T McPhail, David Hahn, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics. Expert opinion on drug metabolism & toxicology 17 (1) (2020)
Abbie D Leino, Chie Emoto, Tsuyoshi Fukuda, Michael Privitera, Alexander A Vinks, Raymond T Chung
Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 19 (10) (2019)
Laura B Ramsey, Tomoyuki Mizuno, Alexander A Vinks, Maureen M O'Brien
Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib. Pediatric blood & cancer 66 (5) (2019)
Alexander A Vinks, Nieko C Punt, Frank Menke, Eric Kirkendall, Dawn Butler, Thomas J Duggan, DonnaMaria E Cortezzo, Sam Kiger, Tom Dietrich, Paul Spencer, Rob Keefer, Kenneth D R Setchell, Junfang Zhao, Joshua C Euteneuer, Tomoyuki Mizuno, Kevin R Dufendach
Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in Neonates. Clinical pharmacology and therapeutics 107 (1) (2019)

Alexander A Vinks.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alexander A Vinks